Mark A. Pearson

9.4k citations

80 papers · 4.0k · 1 hit paper · h-index 29

Impact in

Hematology top 1%
- Acute Myeloid Leukemia Research
Molecular Biology top 5%
- Retinoids in leukemia and cellular processes
- Protein Degradation and Inhibitors
- Ubiquitin and proteasome pathways
- Metabolism, Diabetes, and Cancer

Papers in

Hematology 8
Economics and Econometrics 13
- Fiscal Policy and Economic Growth 7

Co-authors: Pier Giuseppe Pelicci (7 shared papers)Roberta Carbone (3 shared papers)Saverio Minucci (3 shared papers)Ettore Appella (2 shared papers)Marta Fagioli (2 shared papers)Pier Paolo Pandolfi (1 shared paper)Carla Sebastiani (1 shared paper)Yuichiro Higashimoto (1 shared paper)
Journals: Fiscal Studies (3 papers)European Respiratory Journal (3 papers)eLife (2 papers)Molecular Cancer Therapeutics (2 papers)Proceedings of the National Academy of Sciences (2 papers)
Partner nations: United States France Austria

In The Last Decade

Mark A. Pearson

72 papers receiving 3.8k citations

Mark A. Pearson's Hit Papers

align trajectories log scale

PML regulates p53 acetylation and premature senescence induced by oncogenic Ras 2000 · 707 citations

What are hit papers?

Paper score: A paper's citations measured against the top-1% bar of its own field and year: the square root of citations ÷ bar, so 1 means right at the bar and 2 means four times its citations. The bar blends the citation counts that enter the top 1% of the paper's subfields in its year (weighted 89.5%), of those subfields over all years (0.5%) and of its year across all fields (10%); a subfield and year with fewer than 400 papers takes its year's bar. Papers from 2026 are not scored yet: in an unfinished year, when a paper appeared matters more than how it is cited.

Hit paper: A paper cited at least 1.5× the top-1% bar of its field and year: a paper score of at least √1.5.

2000 Nature

Peers

Countries citing papers authored by Mark A. Pearson

Since Specialization

Citations

This map shows the geographic impact of Mark A. Pearson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Pearson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Pearson more than expected).

Fields of papers citing papers by Mark A. Pearson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Pearson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Pearson. The network helps show where Mark A. Pearson may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark A. Pearson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark A. Pearson Line = papers co-authored together Mark A. Pearson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 80 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	PML regulates p53 acetylation and premature senescence induced by oncogenic Ras Nature ·Mark A. Pearson, Roberta Carbone, Carla Sebastiani, Mario Cioce, Marta Fagioli, Shinichi Saito, Yuichiro Higashimoto, Ettore Appella, Saverio Minucci, Pier Paolo Pandolfi, Pier Giuseppe Pelicci Hit paper breakdown →	2000	707
2	Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors Cancer Cell ·Constantine S. Mitsiades, Nicholas Mitsiades, Ciaran J. McMullan, Vassiliki Poulaki, Reshma Shringarpure, Masaharu Akiyama, Teru Hideshima, Dharminder Chauhan, Marie G. Joseph, Towia Aron Libermann, Carlos Garcı́a-Echeverrı́a, Mark A. Pearson, Francesco Hofmann, Kenneth Carl Anderson, Andrew L. Kung	2004	501
3	In vivo antitumor activity of NVP-AEW541—A novel, potent, and selective inhibitor of the IGF-IR kinase Cancer Cell ·Carlos Garcı́a-Echeverrı́a, Mark A. Pearson, Andreas Marti, Thomas Meyer, Juergen Mestan, Johann Zimmermann, Jiaping Gao, Josef Brueggen, Hans‐Georg Capraro, Robert Cozens, Dean B. Evans, Doriano Fabbro, Pascal Furet, Diana Graus Porta, Janis Liebetanz, Georg Martiny‐Baron, Stephan Ruetz, Francesco Hofmann	2004	464
4	Deconstructing PML‐induced premature senescence The EMBO Journal ·Oliver Bischof, Olivier Kirsh, Mark A. Pearson, Koji Itahana, Pier Giuseppe Pelicci, Anne Dejean	2002	187
5	The PML/RAR alpha oncoprotein is a direct molecular target of retinoic acid in acute promyelocytic leukemia cells Blood ·JV Raelson, Clara Nervi, Andreas Rosenauer, Luana Benedetti, Yury Monczak, Mark A. Pearson, Pier Giuseppe Pelicci, WH Jr Miller	1996	185
6	PML NBs associate with the hMre11 complex and p53 at sites of irradiation induced DNA damage Oncogene ·Roberta Carbone, Mark A. Pearson, Saverio Minucci, Pier Giuseppe Pelicci	2002	154
7	Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition Nature Chemical Biology ·Anja F. Hohmann, Laetitia J. Martin, Jessica L. Minder, Jae‐Seok Roe, Junwei Shi, Steffen Steurer, Gerd Bader, Darryl B. McConnell, Mark A. Pearson, Thomas Gerstberger, Teresa Gottschamel, Diane Thompson, Yutaka Suzuki, Manfred Koegl, Christopher R. Vakoc	2016	143
8	PML interaction with p53 and its role in apoptosis and replicative senescence Oncogene ·Mark A. Pearson, Pier Giuseppe Pelicci	2001	107
9	Impairment of p53 acetylation, stability and function by an oncogenic transcription factor The EMBO Journal ·Alessandra Insinga, Silvia Monestiroli, Simona Ronzoni, Roberta Carbone, Mark A. Pearson, Giancarlo Pruneri, G Viale, Ettore Appella, Pier Giuseppe Pelicci, Saverio Minucci	2004	104
10	Werner syndrome helicase is a selective vulnerability of microsatellite instability-high tumor cells eLife ·Simone Lieb, Silvia Blaha-Ostermann, Elisabeth Kamper, Janine Rippka, Cornelia Schwarz, Katharina Ehrenhöfer-Wölfer, Andreas Schlattl, Andreas Wernitznig, Jesse Lipp, Kota Nagasaka, Petra van der Lelij, Gerd Bader, Minoru Koi, A. Goel, Ralph A. Neumüller, Jan‐Michael Peters, Norbert Kraut, Mark A. Pearson, Mark P. Petronczki, Simon Wöhrle	2019	100
11	Enhanced sensitivity to IGF-II signaling links loss of imprinting of IGF2 to increased cell proliferation and tumor risk Proceedings of the National Academy of Sciences ·Atsushi Kaneda, Chiaochun J. Wang, Raymond Cheong, Winston Timp, Patrick Ogola Onyango, Bo Wen, Christine A. Iacobuzio–Donahue, Rolf I. OHLSSON, Rita Andraos, Mark A. Pearson, Alexei A. Sharov, Dan L. Longo, Minoru S.H. Ko, Andre Levchenko, A FEINBERG	2007	87
12	3D printed cellular solid outperforms traditional stochastic foam in long-term mechanical response Scientific Reports ·Amitesh Maiti, Ward Small, James P. Lewicki, Todd H. Weisgraber, Eric B. Duoss, Sarah C. Chinn, Mark A. Pearson, Christopher M. Spadaccini, Robert S. Maxwell, Thomas S. Wilson	2016	84
13	Synthetic lethality between the cohesin subunits STAG1 and STAG2 in diverse cancer contexts eLife ·Petra van der Lelij, Simone Lieb, Julian Jude, Gordana Wutz, Catarina P. Santos, Katrina J. Falkenberg, Andreas Schlattl, Jozef Ban, Raphaela Schwentner, Thomas Walter Hoffmann, Heinrich Kovar, Francisco X. Real, Todd A. Waldman, Mark A. Pearson, Norbert Kraut, Jan‐Michael Peters, Johannes A. Zuber, Mark P. Petronczki	2017	82
14	Taxing Profits in a Global and Economy: Domestic and International Issues Michael Devereux, Mark A. Pearson, Peter Birch Sørensen	1992	71
15	Trends in the North American Frac Industry: Invention through the Shale Revolution SPE Hydraulic Fracturing Technology Conference and Exhibition ·Leen Weijers, Chris A. Wright, Mike Mayerhofer, Mark A. Pearson, Larry G. Griffin, Paul M. Weddle	2019	71
16	Taxing profits in a global economy Michael Devereux, Mark A. Pearson, Peter Birch Sørensen	1991	71
17	Cell death induction by the acute promyelocytic leukemia-specific PML/RARα fusion protein Proceedings of the National Academy of Sciences ·Pierfrancesco Ferrucci, Francesco Grignani, Mark A. Pearson, Marta Fagioli, Ildo Nicoletti, Pier Giuseppe Pelicci	1997	57
18	SrI 2 scintillator for gamma ray spectroscopy Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE ·Nerine J. Cherepy, Benjamin W. Sturm, Owen B. Drury, T. A. Hurst, Steven A. Sheets, Larry E. Ahle, C. K. Saw, Mark A. Pearson, Sheila N. Payne, Arnold Burger, L. A. Boatner, Joanne O. Ramey, Edgar V. van Loef, Jarek Glodo, Rastgo H. Hawrami, William M. Higgins, K.S. Shah, W.W. Moses	2009	50
19	UNEMPLOYMENT AND OTHER NONEMPLOYMENT BENEFITS Oxford Review of Economic Policy ·Sveinbjörn Blöndal, Mark A. Pearson	1995	46
20	Psychomotor slowing in older patients with major depression: Relationships with blood flow in the caudate nucleus and white matter lesions Psychiatry Research Neuroimaging ·Ian Bernard Hickie, Sharon Linda Naismith, Philip B. Ward, Craig L. Little, Mark A. Pearson, Elizabeth Scott, Philip Bowden Mitchell, Kay A Wilhelm, G. H. PARKER	2007	40

About Mark A. Pearson

Mark A. Pearson is a scholar working on Hematology, Economics and Econometrics, Accounting, Oncology and Molecular Biology, having authored 80 papers that have together received 4.0k indexed citations. Recurring topics across this work include Corporate Taxation and Avoidance (7 papers), Fiscal Policy and Economic Growth (7 papers), Retinoids in leukemia and cellular processes (6 papers), Cancer-related Molecular Pathways (6 papers), Protein Degradation and Inhibitors (3 papers), Local Government Finance and Decentralization (3 papers), Hydraulic Fracturing and Reservoir Analysis (3 papers) and Social Policy and Reform Studies (3 papers). The work is most often cited by research in Hematology (664 citations), Molecular Biology (2.4k citations), Oncology (783 citations), Endocrinology, Diabetes and Metabolism (424 citations) and Cancer Research (354 citations). Mark A. Pearson has collaborated with scholars based in United States, France and Austria. Frequent co-authors include Pier Giuseppe Pelicci, Roberta Carbone, Saverio Minucci, Ettore Appella, Marta Fagioli, Pier Paolo Pandolfi, Carla Sebastiani, Yuichiro Higashimoto, Shinichi Saito and Mario Cioce. Their work appears in journals such as Fiscal Studies, European Respiratory Journal, eLife, Molecular Cancer Therapeutics and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Mark A. Pearson

Impact in

Papers in i

In The Last Decade

Mark A. Pearson

Mark A. Pearson's Hit Papers

Peers

Countries citing papers authored by Mark A. Pearson

Fields of papers citing papers by Mark A. Pearson

All Works

About Mark A. Pearson

Explore authors with similar magnitude of impact

Papers in